How to Get Rid of a Plantar Fibroma

Plantar fibromas are stubborn. These firm, benign nodules grow within the plantar fascia on the sole of your foot, and unlike many soft-tissue lumps, they rarely disappear on their own. Treatment ranges from steroid injections and radiation to minimally invasive procedures and, in resistant cases, surgery. The challenge is that recurrence rates are high across nearly every approach, so “getting rid of” a plantar fibroma often means managing it through a sequence of interventions rather than expecting a single cure.

What You’re Dealing With

A plantar fibroma, also called Ledderhose disease when there are multiple nodules or more widespread involvement, is a fibroproliferative condition. The nodule forms when myofibroblasts, specialized cells that generate internal pulling forces, proliferate within the plantar fascia and produce excess collagen.¹ The condition goes through phases: an active proliferative stage, a nodule-forming stage, and a later residual phase that is more collagenous and less cellular.² Most nodules sit along the central cord of the plantar fascia, and roughly a third of people have multiple lesions rather than a single lump.³

Not every plantar fibroma hurts. About half of people with confirmed fibromas report pain, and pain tends to correlate with certain imaging characteristics like fluid-signal changes and muscle involvement around the nodule.³ If your fibroma is small, painless, and not growing, watching it may be perfectly reasonable. But if it hurts when you stand, walk, or wear shoes, you have several treatment tiers to consider.

First-Line Conservative Measures

Most clinicians start with the least invasive options. Cushioned insoles, arch supports, or custom orthotics can redistribute pressure away from the nodule. Physical therapy focused on stretching and strengthening the plantar and surrounding muscle groups, sometimes combined with modalities like TENS or deep oscillation therapy, can help reduce discomfort.⁴ These approaches do not shrink the fibroma. They aim to make it tolerable so you can walk and stay active while deciding whether to escalate treatment.

Corticosteroid injections directly into the nodule are a common next step. One protocol combining needle fenestration (repeated puncturing of the fibroma with a needle) and triamcinolone injection showed significant reductions in both pain and lesion volume that lasted at least 12 months in case reports.⁵ However, the broader clinical picture for steroid injections is that they tend to offer short-term symptom relief but are limited by recurrence.⁶ Repeated steroid injections also carry a risk of weakening the surrounding tissue, so most clinicians limit the number of rounds.

Radiation Therapy for Early-Stage Disease

Radiation might sound aggressive for a benign lump on your foot, but low-dose electron beam therapy has become one of the more studied options for plantar fibromatosis, particularly when the disease is still in its earlier, more cellular phase. A study of 33 patients reported that 94% rated the treatment a success, and radiation improved pain during walking at about four in five treated sites.⁷ The same study found that roughly a quarter of treated sites eventually progressed within the radiation field, though some of those were successfully reirradiated, bringing the final local control rate to about 83%.

Radiation works best as a stabilizer. It aims to halt or slow disease progression rather than eliminate the nodule entirely. There were no significant late side effects reported in that series, even with repeat treatment. Still, postoperative radiation (given after surgery to prevent regrowth) is a more contentious choice. One surgical series found that while adjuvant radiation can reduce recurrence after fasciectomy, it should be used very selectively because of potential long-term side effects in that context.⁸ The distinction matters: standalone radiation for an intact fibroma carries different risk-benefit math than radiation delivered into a postsurgical wound bed.

Shockwave Therapy and Cryoablation

If injections are not enough and you want to avoid both radiation and surgery, two procedures have shown promise in small studies. Extracorporeal shockwave therapy (ESWT) delivers focused acoustic pulses to the fibroma. In one study, ESWT significantly reduced fibroma thickness (from roughly 4.4 mm to 2.6 mm on average at long-term follow-up) and softened all treated nodules, though none completely disappeared.⁹ A separate case report documented complete pain relief and restored function after three weekly shockwave sessions in a patient with bilateral disease.¹⁰

Cryoablation takes a different approach: a probe is inserted into the fibroma under ultrasound guidance and the tissue is frozen. A study of patients whose average worst pain score started at about 7 out of 10 found that scores dropped to under 1 after treatment, with improvement sustained at 12 months. All patients reported improved walking and stopped needing pain medication, with no major complications.¹¹ Symptom improvement typically appeared within two to four weeks. Cryoablation is still relatively new for this condition and is not widely available, but the early results are striking for a procedure that requires only local anesthesia and minimal downtime.

Collagenase Injections

Collagenase clostridium histolyticum (CCH), already approved for Dupuytren contracture in the hand, has been studied as an injectable option for plantar fibromas. The logic is straightforward: the fibroma is largely collagen, and this enzyme breaks collagen down. A dose-ranging study found that the highest dose tested (2.25 mg/mL) produced improvement in nodule hardness in every participant, with foot function scores improving by roughly 84% from baseline.¹² A case report in a pediatric patient who had already failed surgery also documented successful treatment with a single collagenase injection.¹³

The catch is that CCH is not currently approved specifically for plantar fibromatosis, and the manufacturer of the branded product (Xiaflex) actually discontinued its production for Dupuytren contracture in the United States in 2020 due to commercial reasons, though it remains available in some other countries and may return to market. If your clinician has access to it, the data so far are encouraging but limited to small studies. Larger trials are needed before collagenase can be called a reliable standard treatment for this condition.

When Surgery Becomes the Best Option

Surgery tends to be reserved for fibromas that cause significant pain, have failed conservative treatment, or are large enough to interfere with daily life. How much tissue the surgeon removes makes an enormous difference in whether the fibroma comes back. A long-term single-center study found that simply shelling out the nodule (local resection) had a 100% recurrence rate, while removing the entire plantar fascia (total fasciectomy) brought recurrence down to 25%.¹⁴ A systematic review confirmed the pattern, reporting recurrence rates of about 67% after local resection, 42% after wide resection, and 27% after complete fasciectomy.¹⁵

Those numbers explain why surgeons who treat plantar fibromatosis generally favor wider excisions. But removing the entire plantar fascia is not a trivial operation. The plantar fascia is a load-bearing structure that supports your arch. Losing it changes the biomechanics of your foot, and recovery involves weeks of limited weight-bearing. Potential complications include wound-healing problems, nerve injury, and changes in how your foot handles pressure during walking. For this reason, surgery is genuinely a last resort, not a quick fix, and the high recurrence rates even after aggressive resection mean you and your surgeon should have realistic expectations going in.

How Plantar Fibromas Affect Walking

Even before you treat a plantar fibroma, it is worth understanding what it does to your gait, because that shapes which treatments matter most. A case-control study comparing people with painful Ledderhose disease to matched controls found that patients had significantly increased peak pressure and force-time integrals at the heel and toes, with decreased loading through the midfoot.¹⁶ In plain terms, people unconsciously shift weight away from the fibroma site, overloading other parts of the foot. Over time, that compensation can cause secondary problems: heel pain, toe pain, or discomfort in the opposite foot from favoring the affected side. This is one reason why even conservative measures like orthotics can matter, as they help normalize how pressure is distributed before compensatory patterns become entrenched.

Getting the Right Diagnosis

Before pursuing any treatment, you need to be sure the lump on your foot actually is a plantar fibroma and not something else. Many clinicians can diagnose one by feel during a physical exam: a firm, fixed nodule within the arch, attached to the plantar fascia. But imaging confirms it and rules out other possibilities. Ultrasound is generally considered the first-line imaging tool because plantar fibromas appear as distinct low-echogenicity nodules that stand out against the bright, echogenic normal fascia, making even small fibromas easy to spot.¹⁷ MRI can miss smaller fibromas because their low signal intensity looks similar to normal fascia on certain sequences.¹⁸ MRI becomes more useful for larger or atypical lesions, or when the clinician needs to rule out a soft-tissue tumor that might require biopsy.

Ultrasound also has a practical advantage: it is fast, cheap, and can be done in the same visit as an injection procedure. If your doctor plans to do a steroid or collagenase injection, ultrasound guidance helps ensure the needle goes into the right spot.

Conditions That Travel Together

Plantar fibromatosis belongs to a family of fibrotic conditions. It shares pathology with Dupuytren disease (thickening and contracture of tissue in the palm) and Peyronie disease (fibrosis of penile tissue).¹⁹ If you have one of these conditions, the odds of having another are higher than in the general population. In a study of 730 men with Dupuytren disease, about 22% self-reported also having plantar fibromatosis, and about 9% reported Peyronie disease.²⁰

Diabetes also appears frequently alongside plantar fibromas. In the large MRI series mentioned earlier, over half of patients with plantar fibromas had diabetes.³ Whether diabetes directly drives fibroma formation or whether both conditions share underlying metabolic and genetic factors remains unclear. A genome-wide study identified two genetic variants associated with plantar fascial disorders, one located within a gene involved in the body’s inflammatory response to tissue damage, suggesting that inherited differences in how your body handles inflammation and tissue remodeling may partly explain who develops fibromas and who does not.²¹

Choosing a Treatment Path

There is no single algorithm that fits every patient, but the general progression looks like this. If your fibroma is small and not especially painful, start with offloading strategies: good shoes, cushioned insoles, avoidance of activities that press directly on the nodule. If pain persists, a corticosteroid injection can buy time and comfort, though you should expect the benefit may fade. For fibromas that are growing or causing significant functional trouble, the conversation shifts to radiation (best before surgery, ideally in the earlier active phase), shockwave therapy, or cryoablation if available. Collagenase injections remain promising but are not yet widely accessible. Surgery stays in reserve for fibromas that resist everything else or that have grown large enough to cause serious disability, with the understanding that a wider excision offers the best chance of lasting relief but at the cost of a longer recovery and permanent changes to foot mechanics.

One practical note: if your fibroma is painless, you may not need to do anything at all. The condition is benign and does not become cancerous. Some fibromas stay the same size for years. Monitoring with periodic ultrasound is a reasonable plan, and it avoids the risks that come with any intervention. Treatment makes sense when the fibroma hurts, when it is growing, or when it is forcing you to change how you walk, but not simply because it is there.

Why Recurrence Is So Common

The frustrating reality of plantar fibromatosis is that the disease is driven by the cells themselves, not by a single removable structure. Even after surgery, residual myofibroblasts left at the margins can restart the process. The collagen-producing biology that built the original nodule is not confined to the nodule; it exists throughout the fascia and potentially in surrounding tissue. This is why local excisions, which remove only the obvious lump, have such high recurrence rates compared to total fasciectomy, which removes the entire fascial sheet the disease lives in.¹⁵

Radiation, by contrast, works on the cellular level. It targets the proliferating cells responsible for nodule growth, which is why it can slow progression even without physically removing anything. The tradeoff is that it works best early, before the nodule transitions into its mature, heavily collagenous phase, when there are fewer actively dividing cells to target. If you are considering radiation, earlier generally means better results.

Understanding the recurrence issue also helps frame expectations for newer treatments like collagenase and cryoablation. Even when these procedures dramatically reduce pain and improve function, the underlying tendency toward fibrosis may persist. Long-term follow-up data are still limited for most of these approaches. Treating a plantar fibroma is less like removing a mole and more like managing a condition with a tendency to recur, and the best outcomes come from a clinician who is familiar with the full range of options and can adjust the plan over time.